8th Annual Spring to Life

CONFERENCE ON LEUKEMIAS 2021

May 14-15, 2021

Proudly Hosted by New York Oncology Hematology, PC

PROUDLY HOSTED BY:

Image
Image

EVENT INFORMATION

  • This is a CME-Accredited Online LIVE Broadcast
  • Upon registration, confirmation will be provided via email
  • Login information and instructions will be emailed to you prior to the event



    Next quote »

    "Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

    -Makenzi Evangelist, M.D., New York Oncology Hematology

    “The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

    -Nischala Ammannagari, M.D., New York Oncology Hematology

    Registration

    Please click here if you would like to be notified when registration is open. We hope to see you in 2020!
    S2L | Registration HCP

    PROGRAM OVERVIEW

    The focus of the 10th Annual Spring to Life Conference is Aggressive Lymphomas. The purpose of this conference is to educate practitioners and update their knowledge of the biological pathways, diagnosis, current guidelines, and the existing and emerging therapies for the management of patients with Lymphoma.

    TARGET AUDIENCE

    The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers with an interest in the care of patients with lymphoma.

    LEARNING OBJECTIVES

    After participating in this activity, learners will be better able to:

    • Understand the current classification system of the lymphoma
    • Discuss updated data on novel agents and therapeutic approaches for patients with aggressive lymphoma.
    • Discuss current standard of care approach in patient with newly diagnosed and relapsed refractory aggressive B cell lymphoma and T cell lymphoma.
    • Understand the diagnostic and management approaches in patient with uncommon presentation of lymphoma and CNS lymphoma.
    • Understand the disease process and treatment strategies in patients with Hodgkin Lymphoma.
    • Identify the unmet need and upcoming strategies in elderly patients with lymphoma.
    • Understand the complex diagnosis paradigm and management of thrombotic microangiopathies
     
     
     

    This Activity Is Planned By myMedEd, Inc.

    Image
    Educational Partners
    Image
    Image

    Accredited Provider

    Image
    Accredited Provider
    Image
    Educational Partner
    ImageImage

    This Activity Is Planned By myMedEd, Inc.

    Image